Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Frontier Biotechnologies Co. Ltd.
DescriptionLong-acting viral entry inhibitor targeting HIV gp41
Molecular Target HIV gp41
Mechanism of ActionViral entry inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV-1 infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today